Sponsor

Zymeworks BC Inc.

Clinical research sponsor

Published trials4
Recruiting shown2
Roles2
SourceClinicalTrials.gov

Clinical trials

4 shown
A Study of ZW251 in Participants With Advanced Solid TumorsNCT07164313 · lead sponsor · 2025-10-21
RECRUITING
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing CancersNCT06523803 · lead sponsor · 2024-09-30
TERMINATED
A Dose Finding Study of ZW49 in Patients With HER2-Positive CancersNCT03821233 · lead sponsor · 2019-04-15
COMPLETED
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)NCT05035836 · collaborator · 2021-11-16
RECRUITING

Sponsor roles

lead sponsor3
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.